Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Videos
Cardiology
27 Sep 2016
Congress Review – ESC 2016
Don’t miss our congress review in our EMJ Cardiology 4.1 2016 eJournal, coming soon…
Respiratory
27 Sep 2016
An interview with Dr Oliver Eickelberg at the 2016 ERS Congress
An interview with Dr Oliver Eickelberg (Chairman, Comprehensive Pneumology Center) at the 2016 European Respiratory Society Congress, London, United…
Respiratory
27 Sep 2016
An interview with Prof Nicholas Hill at the 2016 ERS Congress
An interview with Prof Nicholas Hill (Professor of Medicine, Tufts University) at the 2016 European Respiratory Society Congress, London, United Kingdom.
Respiratory
27 Sep 2016
Congress Review – ERS 2016
Don’t miss our congress review in our EMJ Respiratory 4.1 2016 eJournal, available now at: https://www.emjreviews.com/therapeutic-area/respiratory/
Neurology
19 Jul 2016
The Role of IL-6 in Autoimmune Disease
Rheumatoid arthritis, or RA, is an incompletely understood disorder. The complex pathophysiology of RA is regulated in part by a network of different…
Oncology
17 Jun 2016
Personalised screening for breast cancer care
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from…
Neurology
14 Jun 2016
EAN 2016 – Prof Günther Deuschl
Prof Gunther Deuschl’s press conference at EAN 2016.EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof John England – Part 2
Part 2 of Prof Raad Shakir’s & Prof John England’s press conference on ‘Neurological expertise and the Zika epidemic – Europe needs to get prepared for…
Neurology
14 Jun 2016
EAN 2016 – Prof Raad Shakir – Part 1
Part 1 of Prof Raad Shakir’s & Prof John England’s press conference on ‘Neurological expertise and the Zika epidemic – Europe needs to get prepared for…
Neurology
14 Jun 2016
EAN 2016 – Prof Mads Henrik Ravnborg
Prof Mads Henrik Ravnborg’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof Franz Fazekas
Prof Franz Fazekas’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Neurology
14 Jun 2016
EAN 2016 – Prof Gunhild Waldemar
Prof Gunhild Waldemar’s press conference at EAN 2016. EMJ Neurology 4.1 2016 coming soon, subscribe for free today!
Dermatology
14 Jun 2016
Overview of ZPL-3893787 (ZPL-389) clinical trial for atopic dermatitis
Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, gives an overview of a phase 2a proof-of-concept clinical trial evaluating ZPL…
Dermatology
14 Jun 2016
Phase 2a trial of ZPL-3893787 (ZPL-389), a histamine H4 receptor antagonist, for atopic dermatitis
Thomas Werfel, MD, from Hannover Medical School, Hannover, Germany, discusses the design and outcomes from a phase 2a proof-of-concept clinical trial…
Urology
14 Jun 2016
Innovation in Education – EAU 2016
Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now…
Oncology
14 Jun 2016
Translating genomics to precision medicine for breast cancer care: Ongoing clinical studies
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
Identifying breast cancer patients who can be spared chemotherapy, evidence from recent studies
The Oncotype DX® 21-gene Recurrence Score® result stratifies patients with breast cancer into low-, intermediate- and high-risk groups that correspond to…
Oncology
14 Jun 2016
Impact of phase 3 PlanB trial on evidence-based clinical practice for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
5-year outcomes from PlanB: Phase 3 trial of 21-gene Recurrence Score® result in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Oncology
14 Jun 2016
Overview of prospective phase 3 PlanB trial of 21-gene Recurrence Score® result in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Oleg Gluz, MD, from the West German…
Urology
14 Jun 2016
An interview with Professor Theo M. de Reijke at the 2016 EAU Congress
An interview with Professor Theo M. de Reijke (Academic Medical Center, Amsterdam, Netherlands) at the 2016 European Association of Urology Congress…
Urology
14 Jun 2016
An interview with Doctor Evangelos Liatsikos at the 2016 EAU Congress
An interview with Doctor Evangelos Liatsikos (University of Patras, Patras, Greece) at the 2016 European Association of Urology Congress, Munich, Germany.
Urology
14 Jun 2016
An interview with Doctor Murat Arslan at the 2016 EAU Congress
An interview with Doctor Murat Arslan (Izmir University, Izmir, Turkey) at the 2016 European Association of Urology Congress, Munich, Germany.
Urology
14 Jun 2016
Congress Review – EAU 2016
Don’t miss our congress review in our EMJ Urology 4.1 2016 eJournal, available now at…
Urology
14 Jun 2016
Breast cancer in Europe: Epidemiology and outcomes
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jan-Willem Coebergh, MD, PhD, from…
Oncology
14 Jun 2016
Defining factors that can predict neoadjuvant chemotherapy response in breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…
Oncology
14 Jun 2016
Genetically determining susceptibility of breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Douglas Easton, PhD, from the…
Oncology
14 Jun 2016
Surgical considerations after neoadjuvant treatment for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…
Oncology
14 Jun 2016
Individualisation of breast cancer therapy
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Isabel Rubio, MD, PhD, from Hospital…
Hepatology
14 Jun 2016
ILC 2016 – Dr. James Freeman
Dr. James Freeman’s press conference on ‘High Sustained Virological Response Rates Using Direct Acting Antiviral Treatment For Hepatitis C, Imported Into…
Hepatology
14 Jun 2016
ILC 2016 – Dr. Stefano Brillanti
Dr. Stefano Brillanti’s press conference on ‘Development of Hepatocellular Carcinoma in HCV Cirrhotic Patients Treated with Direct Acting Antivirals’ at…
Hepatology
14 Jun 2016
ILC 2016 – Dr. Stephen Atkinson
Dr. Stephen Atkinson’s press conference on ‘A Genome-Wide Association Study Identifies PNPLA3 and SLC38A4 as Risk LOCI For Alcoholic Hepatitis’ at ILC 2016.
Hepatology
14 Jun 2016
Congress Review – ILC 2016
Don’t miss our congress review in our EMJ Hepatology 4.1 2016 eJournal, coming soon. Subscribe today at…
Hepatology
14 Jun 2016
An interview with Professor Jean-Francois Dufour at the 2016 ILC Congress
An interview with Professor Jean-Francois Dufour (University Clinic Visceral Surgery and Medicine, Bern, Switzerland) at the 2016 International Liver…
Hepatology
14 Jun 2016
An interview with Professor Marina Berenguer at the 2016 ILC Congress
An interview with Professor Marina Berenguer (University of Valencia, Valencia, Spain) at the 2016 International Liver Congress, Barcelona, Spain.
Hepatology
14 Jun 2016
An interview with Professor Cecilia Rodrigues at the 2016 ILC Congress
An interview with Professor Cecilia Rodrigues (University of Lisbon, Lisbon, Portugal) at the 2016 International Liver Congress, Barcelona, Spain.
Allergy & Immunology
14 Jun 2016
SUPREMO Trial: Pathology Quality Assurance
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Jeremy Thomas, MD, from…
Oncology
14 Jun 2016
Opportunities for improved outcomes in breast cancer patients
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from…
Oncology
14 Jun 2016
2005–2015 global analysis of advanced breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD…
Oncology
14 Jun 2016
Imaging biomarkers as a predictive tool in breast cancer management
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Andrew Evans, MRCP, FRCR, from the…
Oncology
14 Jun 2016
Abstracts from the 10th European Breast Cancer Conference
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…
Oncology
14 Jun 2016
Checkpoint inhibitors for triple-negative breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Precision medicine for breast cancer
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Highlights of the 10th European Cancer Conference (EBCC-10) by Dr Giuseppe Curigliano
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Giuseppe Curigliano, MD, PhD, from…
Oncology
14 Jun 2016
Themes of the 10th European Breast Cancer Conference (EBCC-10)
At the 10th European Breast Cancer Conference (EBCC), held in Amsterdam, the Netherlands, from 9 to 11 March 2016, Fatima Cardoso, MD, from the…
Oncology
14 Jun 2016
Understanding the unique aspects of immunotherapy for lung cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…
Oncology
14 Jun 2016
Immunotherapy for head and neck cancer
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…
Oncology
14 Jun 2016
Improving the treatment of advanced renal cell carcinoma
At the German Cancer Congress 2016, held in Berlin, Germany from 24 to 27 February 2016, Viktor Grünwald, MD, PhD, from Hannover Medical School, Hannover…
Oncology
14 Jun 2016
Predictive biomarkers for immunotherapy in non-small cell lung cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Martin Reck, MD, PhD, from the LungenClinic Grosshansdorf…
Oncology
14 Jun 2016
Next-generation sequencing to guide treatment decision-making
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…
Oncology
14 Jun 2016
Introducing next-generation sequencing into the clinical care of cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Matthias Löhr, MD, PhD, from Karolinska Institutet, Stockholm…
Oncology
14 Jun 2016
Early versus delayed use of tyrosine kinase inhibitors for thyroid cancer
Recent advances in the biological understanding of thyroid cancer have led to the development of targeted therapies, such as the tyrosine kinase…
Oncology
14 Jun 2016
Updating the treatment algorithm for metastatic melanoma
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…
Oncology
14 Jun 2016
Changing the treatment landscape of metastatic melanoma
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Axel Hauschild, MD, from University of Kiel, Kiel, Germany…
Oncology
14 Jun 2016
Clinical decision-making for pancreatic cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…
Oncology
14 Jun 2016
The significance of BRCA mutations in pancreatic cancer
At the German Cancer Congress 2016, held in Berlin, Germany, from 24 to 27 February 2016, Thomas Seufferlein, MD, from University of Ulm, Ulm, Germany…
Oncology
14 Jun 2016
Treatment of pancreatic cancer: Overview of the continued progress
Pancreatic cancer is a leading cause of cancer-related deaths in developed countries. At the German Cancer Congress 2016, held in Berlin, Germany, from…
Hematology
13 Jun 2016
The DA-EPOCH-R clinical trial in Burkitt’s lymphoma
Jeremy Abramson, MD, from the Massachusetts General Hospital, Massachusetts, MA, gives an overview of the interim analysis of a multicenter prospective…
Oncology
25 May 2016
KEYNOTE-010: Pembrolizumab versus docetaxel in advanced PD-L1-positive NSCLC
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
ASCEND-2 and ASCEND-3 trials: Ceritinib in ALK-rearranged NSCLC with brain metastases
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
Immune checkpoint inhibitors, durvalumab plus tremelimumab, for non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Solange Peters, MD, PhD…
Oncology
25 May 2016
Immunotherapy for hepatocellular carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Su Pin Choo, MBBS…
Oncology
25 May 2016
Phase 3 LUX-H&N1 trial: Afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Makoto Tahara, MD…
Oncology
25 May 2016
Endocrine therapy in pregnant women with breast cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…
Oncology
25 May 2016
Olaparib and bevacizumab: On the horizon for treating ovarian cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Suresh Kumarasamy, MBBS…
Oncology
25 May 2016
Tumour biomarker changes after neoadjuvant chemotherapy in breast cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Sibylle Loibl, MD, PhD…
Oncology
25 May 2016
From biologics to biosimilars
A biosimilar can be defined as a biological product that demonstrates no clinically meaningful differences to an approved biological product. At the…
Rheumatology
19 Apr 2016
Treating Active HIDS with Canakinumab
The efficacy and safety of canakinumab in active hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS) and the implications of the results for the future treatment of patients with the condition.
Rheumatology
19 Apr 2016
Pathophysiology and Treatment of HIDS
At the American College of Rheumatology Annual Meeting, topic of interest is the pathophysiology and treatment of the condition hyperimmunoglobulinaemia D with periodic fever syndrome (HIDS)
Oncology
19 Apr 2016
Canakinumab in the treatment of tumour necrosis factor receptor-associated periodic syndrome (TRAPS)
At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen…
Rheumatology
19 Apr 2016
Treatment Strategies for TRAPS
At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen Lachmann…
Rheumatology
19 Apr 2016
Treatments for Patients with CAPS
At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Jasmin Kuemmerle…
Gastroenterology
12 Apr 2016
Discussion on mild and moderate IBD treatment led by Prof Geert D’Haens
Took place during the 11th Congress of ECCO.
Gastroenterology
12 Apr 2016
Success factors in the treatment of uncomplicated CD by Dr Pieter Hindryckx
Took place during the 11th Congress of ECCO. Dr Pieter Hindryckx, Department of Gastroenterology, University Hospital of Ghent, Ghent, Belgium considers…
Gastroenterology
12 Apr 2016
Success factors in the treatment of mild-to-moderate UC by Dr Ailsa Hart
Took place during the 11th Congress of ECCO. During this symposium Dr Ailsa Hart, Director, IBD Unit, St Mark’s Hospital, London, UK discusses the…
Oncology
9 Mar 2016
Precision medicine for metastatic breast cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Janice Tsang, MBBS…
Oncology
20 Feb 2016
Overview of a Phase I study of ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
Martin JS Dyer, MA, DPhil, FRCP, FRCPath from the University of Leicester, Leicester, UK, provides an overview of a Phase I study of ONO/GS-4059, a…
Oncology
5 Feb 2016
Roles of targeted therapy and immunotherapy for gastrointestinal cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Atsushi Ohtsu, MD, PhD…
Oncology
5 Feb 2016
ESMO 2015 highlights: Putting ovarian cancer management into perspective
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes…
Oncology
5 Feb 2016
Defining ESMO Clinical Practice Guidelines at ESMO Asia 2015
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Andrés Cervantes, MD…
Oncology
5 Feb 2016
Phase 1b trial of durvalumab plus tremelimumab for advanced non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Johan Vansteenkiste…
Oncology
5 Feb 2016
Update from CheckMate 057: Nivolumab versus docetaxel in advanced non-squamous NSCLC
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Johan Vansteenkiste, MD…
Oncology
5 Feb 2016
Therapeutic advances in immune checkpoint inhibitors for head and neck cancers
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
Oncology
5 Feb 2016
KEYNOTE-028: Phase 1b trial of pembrolizumab in PD-L1-positive nasopharyngeal carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
Oncology
5 Feb 2016
LUX-H&N1: Phase 3 trial of afatinib versus methotrexate for head and neck squamous cell carcinoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Tanguy Seiwert, MD, from…
Oncology
5 Feb 2016
ESMO Clinical Practice Guidelines: Breast cancer case presentation
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Fatima Cardoso, MD, from…
Oncology
5 Feb 2016
Balancing therapeutics and patient access to new cancer drugs
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, ESMO and Congress…
Oncology
4 Feb 2016
Updates from CheckMate 017 and CheckMate 057: Nivolumab, anti-PD1, for non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Martin Reck, MD, PhD…
Oncology
4 Feb 2016
Olaparib: An opportunity for personalised medicine in BRCA-related ovarian cancer
Recently, there have been numerous advances in the biological understanding of ovarian cancer. At the European Society for Medical Oncology (ESMO) Asia…
Oncology
4 Feb 2016
Optimising sequencing of new treatments for prostate cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Karim Fizazi, MD, PhD…
Oncology
4 Feb 2016
A new definition of genetic counselling for ovarian cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Jonathan A. Ledermann…
Oncology
4 Feb 2016
KEYNOTE-010: Pembrolizumab, anti-PD-1, for advanced NSCLC with PD-L1 expression
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Roy S. Herbst, MD, PhD…
Oncology
4 Feb 2016
Improving outcomes from advanced prostate cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Karim Fizazi, MD, PhD…
Oncology
4 Feb 2016
Cardio-oncology in multiple myeloma
Ola Landgren, MD, PhD from National Cancer Institute, Bethesda, MD talks about cardio-oncology in multiple myeloma (MM). In this new era of more…
Oncology
4 Feb 2016
Phase 3 trials of atezolizumab versus standard chemotherapy in PD-L1-selected NSCLC
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Roy S. Herbst, MD, PhD…
Oncology
4 Feb 2016
LUX-Lung 7: Phase 2b trial of afatinib versus gefitinib for EGFR-mutated adenocarcinoma of the lung
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Roy S. Herbst, MD, PhD…
Oncology
4 Feb 2016
AZD9291, an EGFR-TKI, for T790M-mediated resistance in non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Pasi A. Jänne, MD, PhD…
Oncology
4 Feb 2016
LUX-Lung 7: Phase 2b trial of afatinib versus gefitinib for EGFR-mutated lung cancer in first-line
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Pasi A. Jänne, MD, PhD…
Oncology
4 Feb 2016
Oncogene-addicted non-small cell lung cancer
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Pasi A. Jänne, MD, PhD…
Oncology
4 Feb 2016
Quality of life and new therapeutic options for metastatic castration-resistant prostate cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Hilary Glen, MbChB, MSc, PhD, FRCP, of the Beatson West of Scotland Cancer…
Urology
3 Feb 2016
Potential Impact of New Techniques for Benign Prostatic Hyperplasia
An interview with Dr Ian Jackson (Consultant Anaesthetist, York Teaching Hospital NHS Foundation Trust) following the ‘GreenLight™ Laser System for Day…
Urology
3 Feb 2016
Transurethral Prostate Resection for Benign Prostatic Hyperplasia
An interview with Professor Andrea Tubaro (Depratment of Urology, Sant’Andrea Hospital, Sapienza University of Rome) following the ‘GreenLight™ Laser…
Urology
3 Feb 2016
GreenLight Laser Therapy for Benign Prostatic Hyperplasia
An interview with Mr Gordon Muir (Consultant Urological Surgeon, King’s College NHS Foundation Trust) following the ‘GreenLight™ Laser System for Day…
Oncology
2 Feb 2016
Learn more about the ESMO Asia 2015 Congress
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, ESMO and Congress…
Oncology
1 Feb 2016
Delivering the promise of immunotherapy for melanoma
At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Peter Hersey, MD, PhD…
Gastroenterology
25 Jan 2016
An interview with Professor Geert D’Haens at the 23rd UEG Week
An interview with Professor Geert D’Haens (Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands) at the 23rd United European…
Urology
25 Jan 2016
Results of the GOLIATH Study
Professor Andrea Tubaro discusses the results of the GOLIATH study, which compared the Greenlight laser system with TURP in the treatment of benign…
Urology
25 Jan 2016
The Importance of Day-Case Surgery
Dr Ian Jackson describes the importance of day-care surgery for health service economies during the ‘GreenlightTM Laser System for Day-Case Surgery’s…
Oncology
25 Jan 2016
Q&A Session – Impact of the GreenLight Laser System for Day-Case Surgery
Mr Gordon Muir answers questions from the audience about the effect and impact of the Greenlight laser system for day-case surgery, which took place on…
Oncology
20 Jan 2016
Detailed timelines of cancer development
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Peter Van Loo, PhD, from The Francis Crick Institute, London, UK, discusses the…
Oncology
20 Jan 2016
Lifestyle behaviour and cancer prevention
Eileen Kaner, MSc, PhD, Hon FRCP gives an overview of a session focusing lifestyle behaviour and cancer prevention presented at the 2015 National Cancer…
Oncology
20 Jan 2016
Trends in e-cigarette use in England
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Robert West, PhD, from University College London, London, UK, discusses data…
Oncology
20 Jan 2016
Addressing the rapidly changing and diversifying educational needs of clinicians
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Elaine Vickers, PhD, Founder and Principal Trainer of Science Communicated…
Respiratory
14 Jan 2016
Experts’ perspectives on the future of ASV therapy
‘Experts’ perspectives on the future of ASV therapy’ presented at the European Respiratory Society Congress (ERS) 2015, Amsterdam, Netherlands. Speakers…
Respiratory
14 Jan 2016
Detailed results of SERVE-HF and their implications
‘Detailed results of SERVE-HF and their implications’ presented at the European Respiratory Society Congress (ERS) 2015, Amsterdam, Netherlands. Speakers…
Oncology
13 Jan 2016
Cancer survivorship support in the UK and USA
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Rachael Crayton, Oncology Specialist Nurse from Central Manchester NHS Foundation Trust, Manchester, UK, discusses the highlighted key themes from a networking exercise with cancer survivorship programmes in the UK and USA that may be used to enhance these services for patients.
Oncology
13 Jan 2016
Evaluating genomic tests for breast cancer management
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…
Hematology
13 Jan 2016
Safety and Clinical Benefit of HSC Gene Therapy for Wiskott-Aldrich Syndrome
Press brief by Francesca Ferrua, MD, at the American Society of Hematology (ASH) 2015 annual meeting. Dr Ferrua provides an update on the safety and…
Hematology
13 Jan 2016
Lentiviral HSC Gene Therapy for Older Patients with X-Linked Severe Combined Immunodeficiency
Press brief by Suk See De Ravin, MD, PhD, at the American Society of Hematology (ASH) 2015 annual meeting. Dr De Ravin gives an overview of how…
Oncology
2 Jan 2016
Translating cancer immunotherapy to the clinic
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Sergio Quezada, PhD, from University College London, London, UK, discusses…
Hematology
12 Dec 2015
Northstar study: gene therapy for beta-thalassemia major using LentiGlobin BB305 drug product
Press brief by Mark C. Walters, MD, at the American Socitety of Hematology (ASH) 2015 annual meeting. Dr Walters provides an update on the Northstar…
Hematology
12 Dec 2015
Infusion of allogeneic anti-CD19 CAR T-cells is a promising approach after alloHSCT
Press brief by James N. Kochenderfer, MD, at the American Socitety of Hematology (ASH) 2015 annual meeting. Dr Kochenderfer provides an overview of a…
Oncology
12 Dec 2015
Neutropenic sepsis: Medical alert bands in clinical practice
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Ruth Hammond, Vascular Access and IV Nurse Practitioner, and Clinical…
Oncology
12 Dec 2015
Effective control of chemotherapy-induced nausea and vomiting
Chemotherapy-induced nausea and vomiting (CINV) remains a concern for many cancer patients. At the United Kingdom Oncology Nursing Society (UKONS) Annual…
Oncology
12 Dec 2015
UKONS: Engaging the cancer nursing community in the UK
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Richard Henry, President Elect of the UKONS, and Teaching Fellow at the…
Oncology
12 Dec 2015
Myeloma education today
Myeloma UK provides information and support for individuals affected by multiple myeloma. At the United Kingdom Oncology Nursing Society (UKONS) Annual…
Oncology
12 Dec 2015
Out-of-hours support for cancer patients with a modified UKONS telephone triage tool
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Ali Hodge, Advanced Nurse Practitioner for Acute Oncology at The Royal…
Oncology
12 Dec 2015
Tenovus Cancer Care ‘Sing with Us’ choirs
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Rihannon Skilton, Head of Support Line Services, Tenovus Cancer Care…
Oncology
12 Dec 2015
UKONS: Bringing the nursing community together
Natalie Doyle, MSc, RGN, Nurse Consultant at The Royal Marsden NHS Foundation Trust, London, UK, discusses the aims of the United Kingdom Oncology…
Oncology
12 Dec 2015
Healthy lifestyle choices for patients with cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Natalie Doyle, MSc, RGN, Nurse Consultant at The Royal Marsden NHS…
Oncology
12 Dec 2015
Drug development for metastatic castration-resistant prostate cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Hilary Glen, MbChB, MSc, PhD, FRCP, of the Beatson West of Scotland Cancer…
Oncology
12 Dec 2015
Opportunities and challenges in immuno-oncology
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Toby Talbot, MB BS, of Royal Cornwall Hospitals NHS Trust, Truro, UK…
Oncology
12 Dec 2015
Defining patient safety at UKONS Annual Conference 2015
Richard Henry, President Elect of the United Kingdom Oncology Nursing Society (UKONS), and Teaching Fellow at the School of Nursing and Midwifery…
Oncology
12 Dec 2015
Motivational interviewing in healthcare
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Tim Anstiss, MB, MEd, D.Occ.Med, MFSEM, of the Academy for Health Coaching…
Oncology
12 Dec 2015
Prevention and treatment of chemotherapy-induced nausea and vomiting
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Richard Berman, MBBS, MRCGP, FRCP, of The Christie NHS Foundation Trust…
Oncology
12 Dec 2015
ManVan: Mobile cancer support for prostate, testicular and penile cancer
At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Rihannon Skilton, Head of Support Line Services, Tenovus Cancer Care…
Loading posts...
« Previous
1
…
62
63
64
65
66
…
99
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View